COMPARATIVE-ANALYSIS OF IMMUNOLOGICAL RESPONSES TO ORAL (TY21A) AND PARENTERAL (TAB) TYPHOID VACCINES

被引:31
作者
DAMELIO, R
TAGLIABUE, A
NENCIONI, L
DIADDARIO, A
VILLA, L
MANGANARO, M
BORASCHI, D
LEMOLI, S
NISINI, R
MATRICARDI, PM
机构
[1] SCLAVO SPA,IMMUNOFARMACOL LAB,CTR RIC,SIENA,ITALY
[2] UNIV ROME LA SAPIENZA,CTR ARMY HLTH,I-00185 ROME,ITALY
[3] UNIV ROME LA SAPIENZA,INFECT DIS & TROP DIS CLIN,I-00185 ROME,ITALY
关键词
D O I
10.1128/IAI.56.10.2731-2735.1988
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:2731 / 2735
页数:5
相关论文
共 21 条
  • [1] DEMONSTRATION OF SPECIFIC IGA IN HUMAN FECES AFTER IMMUNIZATION WITH LIVE TY21A SALMONELLA-TYPHI VACCINE
    CANCELLIERI, V
    FARA, GM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (03) : 482 - 484
  • [2] CELLULAR AND HUMORAL MODIFICATIONS DURING RESPONSE TO HBSAG VACCINE IN HEALTHY-SUBJECTS
    DAMELIO, R
    LEMOLI, S
    FATTOROSSI, A
    NISINI, R
    MATRICARDI, PM
    PAGANELLI, R
    CABELLO, A
    CHERCHI, M
    SEMINARA, R
    SIRIANNI, MC
    SODDU, S
    CASTAGLIUOLO, PP
    AIUTI, F
    [J]. ANNALES DE L INSTITUT PASTEUR-VIROLOGY, 1985, 136E (04): : 327 - 340
  • [3] DHAM SK, 1982, CLIN EXP IMMUNOL, V48, P389
  • [4] EISENSTEIN TK, 1984, J IMMUNOL, V133, P958
  • [5] FINNEY DJ, 1971, STATISTICAL METHODS, P99
  • [6] ISOLATION AND CHARACTERIZATION OF GAL-E MUTANT TY 21A OF SALMONELLA-TYPHI - CANDIDATE STRAIN FOR A LIVE, ORAL TYPHOID VACCINE
    GERMANIER, R
    FURER, E
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1975, 131 (05) : 553 - 558
  • [7] SAFETY, INFECTIVITY, IMMUNOGENICITY, AND INVIVO STABILITY OF 2 ATTENUATED AUXOTROPHIC MUTANT STRAINS OF SALMONELLA-TYPHI, 541TY AND 543TY, AS LIVE ORAL VACCINES IN HUMANS
    LEVINE, MM
    HERRINGTON, D
    MURPHY, JR
    MORRIS, JG
    LOSONSKY, G
    TALL, B
    LINDBERG, AA
    SVENSON, S
    BAQAR, S
    EDWARDS, MF
    STOCKER, B
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (03) : 888 - 902
  • [8] LEVINE MM, 1987, LANCET, V1, P1049
  • [9] LISSNER CR, 1983, J IMMUNOL, V131, P3006
  • [10] NATH TR, 1977, CLIN EXP IMMUNOL, V30, P38